NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN… Application EP-4082566-A4 European Patent Office 13 Mar 2024
NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN… Application WO-2021127797-A1 World Intellectual Property Organisation (WIPO) 01 Jul 2021